Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001209191-23-002433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-06 | 2023-01-04+ | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale | $37.82 | -4,838 | 17.6K | -22% | -$183.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | S | D | 2,508 | $37.21 | 19,959 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-05 | S | D | 1,641 | $38.22 | 18,318 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.78, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 5, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-01-05 | S | D | 689 | $39.10 | 17,629 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.30, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 5, 2023 at each separate price. |